《国际循环》：关于口服抗凝药治疗，我们如何保持安全性和有效性之间的平衡？
International Circulation: In oral anticoagulant therapy, how can we make the balance between safety and efficacy?
此外，尽管口服抗凝药的实验监测也许并无必要，但还需开发这类药物的解毒剂并对其效果加以检测。
Moreover, although lab monitoring with oral anticoagulant may not be necessary, antidotes of such compounds still need to be developed and tested for their efficacy.
这项研究例证了新型特异性口服抗凝药可改善当前的抗血栓治疗方法，并有有着较为安全的出血特性。
This study exemplifies that novel, specific oral anticoagulants may improve the current antithrombotic strategies while having a safer bleeding profile.
房颤患者需要口服抗凝药，常规应使用裸金属支架，因为裸金属支架只需双重抗栓治疗，不需要三重抗栓治疗。
In patients with atrial fibrillation on oral anticoagulants, the routine indication should be bare metal stents because bare metal stents implies double therapy not triple therapy.
房颤患者需要口服抗凝药，常规应使用裸金属支架，因为裸金属支架只需双重抗栓治疗，不需要三重抗栓治疗。
In patients with atrial fibrillation on oral anticoagulants, the routine indication should be bare metal stents because bare metal stents implies double therapy not triple therapy.
应用推荐